After the first consignment containing vials of coronavirus vaccine "Covishield" were dispatched from the Pune factory, Adar Poonawalla, CEO, Serum Institute of India on Tuesday termed it a historic moment and said the main challenge is to make the v ...
Serum Institute of India (SII) has received the purchase order from the Government of India and 11 million doses of vaccine, Covishield would be available at the price of Rs 200 per vial, said insiders at the SII on Monday. ...
Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday. ...
The Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for I ...
